Jupiter Hematology Oncology is categorized under Hematologists in Jupiter, FL and active since 2004.
Jupiter Hematology Oncology was established in 2004, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Hematologists business, which does work in the B2C market, and is classified as a Hematologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Andres Canova, Principal at the company’s single location by writing to 431 University Boulevard, Jupiter, Florida FL 33458 or by phoning (561) 748-2488. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Jupiter Hematology Oncology |
| Contact Person: | Andres Canova, Principal |
| Address: | 431 University Boulevard, Jupiter, Florida 33458 |
| Phone Number: | (561) 748-2488 |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Hematologists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Jupiter Hematology Oncology was started in 2004 to provide professional Hematologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Andres Canova, Principal for inquiries that concern Jupiter Hematology Oncology by calling the company number (561) 748-2488, as your correspondence is most welcome. Additionally, the physical location of the single location of Jupiter Hematology Oncology can be found at the coordinates 26.89117,-80.1042 as well as the street address 431 University Boulevard in Jupiter, Florida 33458.
For its online presence, you may visit Jupiter Hematology Oncology’s website at and engage with its social media outlets through on Twitter and on Facebook.